A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Ebola Virus Disease

Interventions

BIOLOGICAL

Ad5-EBOV

intramuscular injection

Trial Locations (1)

First affiliated hospital of Zhejiang University, Hangzhou

All Listed Sponsors

collaborator

Beijing Institute of Bioengineering, Academy of Military Medical Sciences

UNKNOWN

collaborator

Tianjin Cansino Biotechnology Inc

INDUSTRY

lead

First Affiliated Hospital of Zhejiang University

OTHER

NCT02401373 - A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China. | Biotech Hunter | Biotech Hunter